ZLD 24.0% 59.5¢ zelira therapeutics limited

Ann: Zelda Enters Strategic Partnership with CannPal, page-20

  1. 1,196 Posts.
    You need to contact them directly, although they may not tell you particulars unless your an investor, they did not provide percentages when I asked just outlined the investment portfolio.

    Merchant Opportunities Fund is managed under Merchant Fund Management, another subsidiary of Merchant Group. The fund gained 89 percent last year, largely benefiting from its long investments in medical marijuana companies Zelda Therapeutics Ltd, AusCann Group Holdings, MMJ PhytoTech and MGC Pharmaceuticals Ltd, said Merchant Group's CEO Andrew Chapman. Merchant Opportunities Fund is also a cornerstone investor in CannPal, another medical marijuana company it expects will either "IPO or reverse takeover in the next couple of months," Chapman said. The fund's bullish bets on cobalt also helped returns, as the metal — used for producing batteries in electric cars — experienced a141 percent rise after reaching a seven-year low on Feb. 1, 2016.
    Merchant Opportunities Fund has A$50 million (about $38 million) in assets and is up 32 percent for the first two months of 2017.
    Merchant Fund Management aims to roll out a resources-focused fund in July which will invest in equities and commodities, Chapman said.
    Other bets that have paid off include investments in lithium companies Kidman Resources and Birimian Ltd; satellite company Sky and Space Global Ltd; biotechnology firm PolyNovo Ltd and gold miner Pantoro Ltd., Chapman said.
 
watchlist Created with Sketch. Add ZLD (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.